Clayton fill-finish facility (second)
Novo Nordisk, Clayton, Johnston County, North Carolina
Clayton fill-finish facility (second) in Clayton, North Carolina is Novo Nordisk’s plant for aseptic fill-finish of injectable obesity/chronic disease medicines. Status: under construction as of June 24, 2024 (construction started). Novo Nordisk announced $4.1 billion and 1,000 jobs. Primary source: novonordisk.com, checked November 1, 2026.
- Status
- Under construction
- Announced investment
- $4.1 billion
- Announced jobs
- 1,000
- Industry
- Pharmaceuticals
- Sheet
- NC-31
- Revised
- November 1, 2026
Status timeline
- Announcednovonordisk.com
- Construction startednovonordisk.com
Filled dots are confirmed by a company, state, SEC or federal source. Dashed dots come from news reports only. Investment and job figures are as announced, not achieved.
Plant facts
| Company | Novo Nordisk |
|---|---|
| Plant | Clayton fill-finish facility (second) |
| Location | Clayton, Johnston County, North Carolina |
| Industry | Pharmaceuticals |
| Product | Aseptic fill-finish of injectable obesity/chronic disease medicines |
| Announced investment | $4.1 billionUSD 4.1B (about DKK 27B) for the facility |
| Announced jobs | 1,000 |
| Last checked | November 1, 2026 |
Sources
- Novo Nordisk announces $4.1B US investment (company release, novonordisk.com, checked November 1, 2026)
Something changed? Send a correction with a link and we'll recheck it.